Stroke outcomes with use of antithrombotics within 24 hours after recanalization treatment

Neurology

Volumn 87, Issue 10, 2016, Pages 996-1002

  Jeong, Han Gil ^a   Kim, Beom Joon ^a   Yang, Mi Hwa ^a   Han, Moon Ku ^a   Bae, Hee Joon ^a   Lee, Seung Hoon ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; CILOSTAZOL; CLOPIDOGREL; DABIGATRAN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; WARFARIN; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ATHEROSCLEROSIS; CLINICAL DECISION MAKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE REGISTRY; DRUG EFFICACY; DRUG SAFETY; DUAL ANTIPLATELET THERAPY; ENDOVASCULAR SURGERY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MIDDLE AGED; MONOTHERAPY; ODDS RATIO; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RECANALIZATION; STROKE PATIENT; TREATMENT OUTCOME; VERY ELDERLY; CEREBROVASCULAR ACCIDENT; COMPLICATION; FACTUAL DATABASE; FIBRINOLYTIC THERAPY; INTRAVENOUS DRUG ADMINISTRATION; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TIME TO TREATMENT;

ADMINISTRATION, INTRAVENOUS; AGED; BRAIN ISCHEMIA; DATABASES, FACTUAL; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOLYTIC THERAPY; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84986214977     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003083     Document Type: Article

References (40)

1. Manning WJ. Role of transesophageal echocardiography in the management of thromboembolic stroke. Am J Cardiol 1997;80:19D-28D
2. Katsanos AH, Giannopoulos S, Frogoudaki A, et al. The diagnostic yield of transesophageal echocardiography in patients with cryptogenic cerebral ischaemia: a metaanalysis. Eur J Neurol 2016;23:569-579
3. Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 2014;13:429-438
4. Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005; 36:1597-1616
5. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41
6. Pepi M, Evangelista A, Nihoyannopoulos P, et al. Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2010;11:461-476
7. Censori B, Colombo F, Valsecchi MG, et al. Early transoesophageal echocardiography in cryptogenic and lacunar stroke and transient ischaemic attack. J Neurol Neurosurg Psychiatry 1998;64:624-627
8. Charbonnel C, Fanon L, Georges JL, et al. Usefulness of transesophageal echocardiography to optimize treatment after ischemic stroke. Ann Cardiol Angeiol 2014;63: 300-306
9. Dawn B, Hasnie AM, Calzada N, et al. Transesophageal echocardiography impacts management and evaluation of patients with stroke, transient ischemic attack, or peripheral embolism. Echocardiography 2006;23:202-207
10. De Castro S, Papetti F, Di Angelantonio E, et al. Feasibility and clinical utility of transesophageal echocardiography in the acute phase of cerebral ischemia. Am J Cardiol 2010;106:1339-1344
11. Harloff A, Handke M, Reinhard M, et al. Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke. Stroke 2006;37:859-864
12. Katsanos AH, Patsouras D, Tsivgoulis G, et al. The value of transesophageal echocardiography in the investigation and management of cryptogenic cerebral ischemia: a singlecenter experience. Neurol Sci 2015;37:629-632
13. Khariton Y, House JA, Comer L, et al. Impact of transesophageal echocardiography on management in patients with suspected cardioembolic stroke. Am J Cardiol 2014; 114:1912-1916
14. Rettig TC, Bouma BJ, van den Brink RB. Influence of transoesophageal echocardiography on therapy and prognosis in young patients with TIA or ischaemic stroke. Neth Heart J 2009;17:373-377
15. Strandberg M, Marttila RJ, Helenius H, et al. Transoesophageal echocardiography should be considered in patients with ischaemic stroke or transient ischaemic attack. Clin Physiol Funct Imaging 2008;28:156-160
16. Tatani SB, Fukujima MM, Lima JA, et al. Clinical impact of transesophageal echocardiography in patients with stroke without clinical evidence of cardiovascular sources of emboli. Arq Bras Cardiol 2001;76:453-461
17. Walpot J, Pasteuning WH, Hoevenaar M, et al. Transesophageal echocardiography in patients with cryptogenic stroke: does it alter their management? A 3-year retrospective study in a single non-referral centre. Acta Clin Belg 2006;61:243-248
18. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:2160-2236
19. Katsanos AH, Psaltopoulou T, Sergentanis TN, et al. Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: a systematic review and diagnostic test accuracy meta-analysis. Ann Neurol 2016;79:625-635
20. Katsanos AH, Spence JD, Bogiatzi C, et al. Recurrent stroke and patent foramen ovale: a systematic review and meta-analysis. Stroke 2014;45:3352-3359
21. Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 2013;81:619-625
22. Kini V, Logani S, Ky B, et al. Transthoracic and transesophageal echocardiography for the indication of suspected infective endocarditis: vegetations, blood cultures and imaging. J Am Soc Echocardiogr 2010;23:396-402
23. Leitman M, Peleg E, Rosenblat S, et al. Transesophageal echocardiography: an overview. Isr Med Assoc J 2001;3: 198-206
24. Merino A, Hauptman P, Badimon L, et al. Echocardiographic "smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces. J Am Coll Cardiol 1992;20:1661-1668
25. Black IW, Hopkins AP, Lee LC, Walsh WF. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol 1991;18:398-404
26. Okura H, Inoue H, Tomon M, Nishiyama S, Yoshikawa T, Yoshida K. Transesophageal echocardiographic detection of cardiac sources of embolism in elderly patients with ischemic stroke. Intern Med 1999;38:766-772
27. Leung DY, Black IW, Cranney GB, Hopkins AP, Walsh WF. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 1994;24:755-762
28. Kupczynska K, Kasprzak JD, Michalski B, Lipiec P. Prognostic significance of spontaneous echocardiographic contrast detected by transthoracic and transesophageal echocardiography in the era of harmonic imaging. Arch Med Sci 2013;9:808-814
29. Katsanos AH, Giannopoulos S, Kosmidou M, et al. Complex atheromatous plaques in the descending aorta and the risk of stroke: a systematic review and meta-analysis. Stroke 2014;45:1764-1770
30. Di Tullio MR, Russo C, Jin Z, et al. Aortic arch plaques and risk of recurrent stroke and death. Circulation 2009; 119:2376-2382
31. Nacu A, Fromm A, Sand KM, Waje-Andreassen U, Thomassen L, Naess H. Age dependency of ischaemic stroke subtypes and vascular risk factors in western Norway: the Bergen Norwegian Stroke Cooperation Study. Acta Neurol Scand 2016;133:202-207
32. Tsivgoulis G, Putaala J, Sharma VK, et al. Racial disparities in early mortality in 1,134 young patients with acute stroke. Neurol Sci 2014;35:1041-1049
33. Ntaios G, Papavasileiou V, Milionis H, et al. Embolic strokes of undetermined source in the Athens Stroke Registry: a descriptive analysis. Stroke 2015;46: 176-181
34. Pagán RJ, Parikh PP, Mergo PJ, et al. Emerging role of cardiovascular CT and MRI in the evaluation of stroke. AJR Am J Roentgenol 2015;204:269-280
35. Baher A, Mowla A, Kodali S, et al. Cardiac MRI improves identification of etiology of acute ischemic stroke. Cerebrovasc Dis 2014;37:277-284
36. Zahuranec DB, Mueller GC, Bach DS, et al. Pilot study of cardiac magnetic resonance imaging for detection of embolic source after ischemic stroke. J Stroke Cerebrovasc Dis 2012;21:794-800
37. Hamilton-Craig C, Sestito A, Natale L, et al. Contrast transoesophageal echocardiography remains superior to contrast-enhanced cardiac magnetic resonance imaging for the diagnosis of patent foramen ovale. Eur J Echocardiogr 2011;12:222-227
38. Wolf ME, Sauer T, Alonso A, Hennerici MG. Comparison of the new ASCO classification with the TOAST classification in a population with acute ischemic stroke. J Neurol 2012;259:1284-1289
39. Desai JA, Abuzinadah AR, Imoukhuede O, et al. Etiologic classification of TIA and minor stroke by A-S-C-O and causative classification system as compared to TOAST reduces the proportion of patients categorized as cause undetermined. Cerebrovasc Dis 2014;38:121-126
40. Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444-1451